Tonghua Dongbao Pharmaceutical Co Ltd (600867) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥62.99 Million ≈ $9.22 Million USD) by net assets (CN¥7.14 Billion ≈ $1.04 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tonghua Dongbao Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Tonghua Dongbao Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 600867 total debt and obligations for a breakdown of total debt and financial obligations.

Tonghua Dongbao Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tonghua Dongbao Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Acer Incorporated
F:AC5G
0.017x
Artisan Partners Asset Management Inc
NYSE:APAM
0.052x
Kinik Co
TW:1560
0.048x
Thule Group AB
ST:THULE
0.007x
Hytera Communications Corp Ltd
SHE:002583
-0.085x
AMP Ltd
AU:AMP
-0.316x
Highwealth Construction Corp
TW:2542
-0.019x
Ero Copper Corp
TO:ERO
0.143x

Annual Cash Flow Conversion Efficiency for Tonghua Dongbao Pharmaceutical Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Tonghua Dongbao Pharmaceutical Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see Tonghua Dongbao Pharmaceutical Co Ltd market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥6.40 Billion
≈ $936.58 Million
CN¥459.74 Million
≈ $67.27 Million
0.072x -39.83%
2023-12-31 CN¥7.22 Billion
≈ $1.06 Billion
CN¥861.52 Million
≈ $126.07 Million
0.119x -9.40%
2022-12-31 CN¥6.55 Billion
≈ $958.41 Million
CN¥863.09 Million
≈ $126.30 Million
0.132x -27.75%
2021-12-31 CN¥6.22 Billion
≈ $910.21 Million
CN¥1.13 Billion
≈ $166.02 Million
0.182x -14.95%
2020-12-31 CN¥5.56 Billion
≈ $813.52 Million
CN¥1.19 Billion
≈ $174.47 Million
0.214x -6.77%
2019-12-31 CN¥5.01 Billion
≈ $732.95 Million
CN¥1.15 Billion
≈ $168.60 Million
0.230x +24.18%
2018-12-31 CN¥4.73 Billion
≈ $692.77 Million
CN¥876.94 Million
≈ $128.32 Million
0.185x -12.56%
2017-12-31 CN¥4.54 Billion
≈ $663.97 Million
CN¥961.19 Million
≈ $140.65 Million
0.212x +15.15%
2016-12-31 CN¥3.95 Billion
≈ $577.31 Million
CN¥725.76 Million
≈ $106.20 Million
0.184x +54.81%
2015-12-31 CN¥2.48 Billion
≈ $362.76 Million
CN¥294.58 Million
≈ $43.11 Million
0.119x +24.69%
2014-12-31 CN¥2.16 Billion
≈ $316.15 Million
CN¥205.89 Million
≈ $30.13 Million
0.095x -13.08%
2013-12-31 CN¥2.02 Billion
≈ $295.04 Million
CN¥221.06 Million
≈ $32.35 Million
0.110x +12.35%
2012-12-31 CN¥1.99 Billion
≈ $291.37 Million
CN¥194.32 Million
≈ $28.44 Million
0.098x +468.21%
2011-12-31 CN¥2.08 Billion
≈ $304.07 Million
CN¥-55.07 Million
≈ $-8.06 Million
-0.027x -128.63%
2010-12-31 CN¥1.73 Billion
≈ $253.53 Million
CN¥160.40 Million
≈ $23.47 Million
0.093x -9.39%
2009-12-31 CN¥1.63 Billion
≈ $238.04 Million
CN¥166.20 Million
≈ $24.32 Million
0.102x +58.67%
2008-12-31 CN¥1.43 Billion
≈ $209.78 Million
CN¥92.31 Million
≈ $13.51 Million
0.064x -18.33%
2007-12-31 CN¥1.53 Billion
≈ $224.47 Million
CN¥120.94 Million
≈ $17.70 Million
0.079x -36.33%
2006-12-31 CN¥1.28 Billion
≈ $186.72 Million
CN¥158.00 Million
≈ $23.12 Million
0.124x +80.01%
2005-12-31 CN¥1.34 Billion
≈ $196.19 Million
CN¥92.23 Million
≈ $13.50 Million
0.069x +592.91%
2004-12-31 CN¥1.33 Billion
≈ $194.05 Million
CN¥13.17 Million
≈ $1.93 Million
0.010x -69.43%
2003-12-31 CN¥1.40 Billion
≈ $205.04 Million
CN¥45.51 Million
≈ $6.66 Million
0.032x +38.36%
2002-12-31 CN¥1.36 Billion
≈ $199.45 Million
CN¥31.99 Million
≈ $4.68 Million
0.023x -72.51%
2001-12-31 CN¥1.38 Billion
≈ $201.72 Million
CN¥117.73 Million
≈ $17.23 Million
0.085x +317.87%
2000-12-31 CN¥1.43 Billion
≈ $208.52 Million
CN¥29.12 Million
≈ $4.26 Million
0.020x +130.19%
1999-12-31 CN¥1.40 Billion
≈ $205.54 Million
CN¥-95.09 Million
≈ $-13.91 Million
-0.068x +71.02%
1998-12-31 CN¥928.90 Million
≈ $135.93 Million
CN¥-216.98 Million
≈ $-31.75 Million
-0.234x --

About Tonghua Dongbao Pharmaceutical Co Ltd

SHG:600867 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.65 Billion
CN¥18.08 Billion CNY
Market Cap Rank
#5342 Global
#1066 in China
Share Price
CN¥9.23
Change (1 day)
-3.45%
52-Week Range
CN¥7.37 - CN¥10.49
All Time High
CN¥23.57
About

Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug tr… Read more